Ragini Kudchadkar, MD, is an Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Kudchadkar specializes in the treatment of metastatic melanoma, basal cell carcinoma and other cutaneous malignancies.
Dr. Kudchadkar is a member of the Discovery and Developmental Therapeutics Research Program at Winship.
Dr. Kudchadkar’s research focuses on signal transduction inhibitors for the treatment metastatic melanoma with a secondary interest in advanced basal cell carcinomas. Her research is focused on the development of novel therapeutic approaches for metastatic melanoma via the discovery of novel drug targets and drug combinations. Her concentration at Emory is in clinical trial development and implementation to improve treatment options for melanoma.